Page 1
USP Medicare Model Guidelines v7.0 Page 1 of 38
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
Analgesics
Analgesics Nonsteroidal Anti-inflammatory Drugs
Analgesics Celecoxib
Analgesics Diclofenac Potassium
Analgesics Diflunisal
Analgesics Etodolac
Analgesics Fenoprofen Calcium
Analgesics Flurbiprofen
Analgesics Ibuprofen
Analgesics Indomethacin
Analgesics Ketoprofen
Analgesics Ketorolac Tromethamine
Analgesics Meclofenamate
Analgesics Mefenamic Acid
Analgesics Meloxicam
Analgesics Nabumetone
Analgesics Naproxen
Analgesics Oxaprozin
Analgesics Piroxicam
Analgesics Sulindac
Analgesics Tolmetin
Analgesics Opioid Analgesics, Long-acting
Analgesics Buprenorphine FDA approved 10/23/2015; New indication for
pain
Fentanyl
Analgesics Hydromorphone
Analgesics Levorphanol Tartrate
Analgesics Methadone Hydrochloride
Analgesics Morphine Sulfate
Analgesics Oxycodone Hydrochloride
Analgesics Oxymorphone Hydrochloride
Analgesics Tramadol Hydrochloride
Analgesics Opioid Analgesics, Short-acting
Analgesics Butorphanol Tartrate
Analgesics Codeine Phosphate
Analgesics Fentanyl Citrate
Analgesics Hydromorphone Hydrochloride
Analgesics Meperidine Hydrochloride
Analgesics Nalbuphine Hydrochloride
Analgesics Oxycodone Hydrochloride
Analgesics Oxymorphone Hydrochloride
Analgesics Pentazocine Lactate
Analgesics Tapentadol
Analgesics Tramadol Hydrochloride
Anesthetics
Anesthetics Local Anesthetics
Anesthetics Lidocaine Hydrochloride
Anesthetics Lidocaine/Prilocaine
Anti-Addiction/ Substance Abuse
Treatment Agents
Alcohol Deterrents/Anti-craving
Acamprosate Calcium
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 2
USP Medicare Model Guidelines v7.0 Page 2 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
Disulfiram
Naltrexone Hydrochloride
Opioid Dependence Treatments
Buprenorphine
Buprenorphine/Naloxone
Naltrexone Hydrochloride
Opioid Reversal Agents
Naloxone Hydrochloride
Smoking Cessation Agents
Bupropion Hydrochloride
Nicotine
Varenicline Tartrate
Antibacterials
Antibacterials Aminoglycosides
Antibacterials Amikacin Sulfate
Antibacterials Gentamicin Sulfate
Antibacterials Kanamycin Sulfate
Antibacterials Neomycin Sulfate
Antibacterials Paromomycin Sulfate
Antibacterials Streptomycin Sulfate
Antibacterials Tobramycin Sulfate
Antibacterials Tobramycin/ Dexamethasone
Antibacterials Beta-lactam, Cephalosporins
Antibacterials
Antibacterials Cefadroxil
Antibacterials Cefazolin
Antibacterials Cephalexin
Antibacterials
Antibacterials Cefaclor
Antibacterials Cefoxitin
Antibacterials Cefprozil
Antibacterials Cefuroxime Axetil
Antibacterials
Antibacterials Cefdinir
Antibacterials Cefditoren Pivoxil
Antibacterials Cefixime
Antibacterials Cefotaxime
Antibacterials Cefpodoxime Proxetil
Antibacterials Ceftazidime
Antibacterials Ceftazidime/Avibactam New FDA Approved Drug, 2/25/15
Antibacterials Ceftibuten Dihydrate
Antibacterials Ceftriaxone Sodium
Antibacterials
Antibacterials Cefepime Hydrochloride
Antibacterials Ceftolozane Sulfate/
Tazobactam
New FDA Approved Drug, 12/19/14
Antibacterials
Antibacterials Ceftaroline fosamil
Antibacterials Beta-lactam, Penicillins
Antibacterials
Antibacterials Amoxicillin
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 3
USP Medicare Model Guidelines v7.0 Page 3 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
Antibacterials Amoxicillin/Clavulanate
Potassium
Antibacterials Ampicillin
Antibacterials Ampicillin Sodium/ Sulbactam
Sodium
Antibacterials
Antibacterials Piperacillin Sodium
Antibacterials Piperacillin Sodium/
Tazobactam Sodium
Antibacterials Ticarcillin Disodium/
Clavulanate Potassium
Discontinued by manufacturer
Antibacterials
Antibacterials Penicillin G Benzathine
Antibacterials Potassium
Antibacterials Procaine
Antibacterials Sodium
Antibacterials Penicillin V Potassium
Antibacterials
Antibacterials Dicloxacillin Sodium
Antibacterials Nafcillin Sodium
Antibacterials Oxacillin Sodium
Antibacterials Beta-lactam, Other
Antibacterials Aztreonam
Antibacterials Doripenem
Antibacterials Ertapenem Sodium
Antibacterials Imipenem/Cilastatin Sodium
Antibacterials Meropenem
Antibacterials Macrolides
Antibacterials Azithromycin
Antibacterials Clarithromycin
Antibacterials Erythromycin Estolate
Antibacterials Ethylsuccinate
Antibacterials Lactobionate
Antibacterials Stearate
Antibacterials Fidaxomicin
Antibacterials Telithromycin Discontinued by manufacturer
Antibacterials Quinolones
Antibacterials Besifloxacin
Antibacterials Ciprofloxacin
Antibacterials Finafloxacin New FDA Approved Drug, 12/17/14
Antibacterials Gatifloxacin
Antibacterials Gemifloxacin Mesylate
Antibacterials Levofloxacin
Antibacterials Moxifloxacin Hydrochloride
Antibacterials Norfloxacin Discontinued by manufacturer
Antibacterials Ofloxacin
Antibacterials Sulfonamides
Antibacterials Sulfacetamide Sodium
Antibacterials Sulfadiazine
Antibacterials Sulfamethoxazole/
Trimethoprim
Antibacterials Tetracyclines
Antibacterials Demeclocycline Hydrochloride
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 4
USP Medicare Model Guidelines v7.0 Page 4 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
Antibacterials Doxycycline Calcium
Antibacterials Hyclate
Antibacterials Minocycline Hydrochloride
Antibacterials Tetracycline Hydrochloride
Antibacterials Antibacterials, Other
Antibacterials
Antibacterials
Antibacterials Trimethoprim
Antibacterials
Antibacterials Vancomycin Hydrochloride
Antibacterials Dalbavancin New FDA Approved Drug, 5/23/14
Antibacterials
Antibacterials Clindamycin Hydrochloride
Antibacterials Palmitate
Antibacterials Lincomycin Hydrochloride
Antibacterials
Antibacterials Nitrofurantoin
Antibacterials
Antibacterials Linezolid
Antibacterials Tedizolid Phosphate New FDA Approved Drug, 6/20/14
Antibacterials
Antibacterials Acetic Acid
Antibacterials Bacitracin
Antibacterials Chloramphenicol Sodium Succinate
Antibacterials Daptomycin
Antibacterials Fosfomycin Tromethamine
Antibacterials Gramicidin
Antibacterials Mafenide Acetate
Antibacterials Methenamine Hippurate
Antibacterials Mandelate
Antibacterials Metronidazole Hydrochloride
Antibacterials Mupirocin Calcium
Antibacterials Polymyxin B Sulfate
Antibacterials Retapamulin
Antibacterials Rifaximin
Antibacterials Telavancin
Antibacterials Tinidazole
Antibacterials Tigecycline
Antibacterials Oritavancin New FDA Approved Drug, 8/9/14
Anticonvulsants
Anticonvulsants Calcium Channel Modifying Agents
Anticonvulsants Ethosuximide
Anticonvulsants Methsuximide
Anticonvulsants Pregabalin
Anticonvulsants Zonisamide
Anticonvulsants Gamma-aminobutyric Acid (GABA)
Augmenting Agents
Anticonvulsants
Anticonvulsants Clobazam
Anticonvulsants Clonazepam
Anticonvulsants Clorazepate Dipotassium
Anticonvulsants Diazepam
Anticonvulsants Lorazepam
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 5
USP Medicare Model Guidelines v7.0 Page 5 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
Anticonvulsants
Anticonvulsants Mephobarbital Discontinued by manufacturer
Anticonvulsants Phenobarbital
Anticonvulsants Primidone
Anticonvulsants
Anticonvulsants Divalproex Sodium
Anticonvulsants Gabapentin
Anticonvulsants Tiagabine Hydrochloride
Anticonvulsants Valproate Sodium
Anticonvulsants Vigabatrin
Anticonvulsants Glutamate Reducing Agents
Anticonvulsants Felbamate
Anticonvulsants Lamotrigine
Anticonvulsants Perampanel
Anticonvulsants Topiramate
Anticonvulsants Sodium Channel Agents
Anticonvulsants Carbamazepine
Anticonvulsants Eslicarbazepine Acetate
Anticonvulsants Ethotoin
Anticonvulsants Fosphenytoin Sodium
Anticonvulsants Oxcarbazepine
Anticonvulsants Phenytoin Sodium
Anticonvulsants Rufinamide
Anticonvulsants
Anticonvulsants Lacosamide
Anticonvulsants Anticonvulsants, Other
Anticonvulsants Briavaracetam New FDA Approved Drug, 2/18/16
Anticonvulsants Levetiracetam
Anticonvulsants
Anticonvulsants Ezogabine
Antidementia Agents
Antidementia Agents Cholinesterase Inhibitors
Antidementia Agents Donepezil Hydrochloride
Antidementia Agents Galantamine Hydrochloride
Antidementia Agents Rivastigmine Tartrate
Antidementia Agents N-methyl-D-aspartate (NMDA) Receptor
Antagonist
Antidementia Agents Memantine Hydrochloride
Antidementia Agents Antidementia Agents, Other
Antidementia Agents Ergoloid Mesylates
Antidepressants
Antidepressants Monoamine Oxidase Inhibitors
Antidepressants Phenelzine Sulfate
Antidepressants Selegiline
Antidepressants Tranylcypromine Sulfate
Antidepressants SSRIs/SNRIs (Selective Serotonin
Reuptake Inhibitors/ Serotonin and
Norepinephrine Reuptake Inhibitors)
Antidepressants Citalopram Hydrobromide
Antidepressants Desvenlafaxine
Antidepressants Duloxetine Hydrochloride
Antidepressants Escitalopram Oxalate
Antidepressants Fluoxetine Hydrochloride
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 6
USP Medicare Model Guidelines v7.0 Page 6 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
Antidepressants Fluvoxamine Maleate
Antidepressants Levomilnacipran Hydrochloride
Antidepressants Maprotiline Hydrochloride
Antidepressants Nefazodone Hydrochloride
Antidepressants Paroxetine Hydrochloride
Antidepressants Sertraline Hydrochloride
Antidepressants Trazodone Hydrochloride
Antidepressants Venlafaxine Hydrochloride
Antidepressants Vilazodone Hydrochloride
Antidepressants Vortioxetine
Antidepressants Tricyclics
Antidepressants Amitriptyline Hydrochloride
Antidepressants Amoxapine
Antidepressants Clomipramine Hydrochloride
Antidepressants Desipramine Hydrochloride
Antidepressants Doxepin Hydrochloride
Antidepressants Imipramine Hydrochloride
Antidepressants Imipramine Pamoate
Antidepressants Nortriptyline Hydrochloride
Antidepressants Protriptyline Hydrochloride
Antidepressants Trimipramine Maleate
Antidepressants Antidepressants, Other
Antidepressants Bupropion Hydrochloride
Antidepressants Mirtazapine
Antidepressants
Antidepressants Aripiprazole
Antidepressants Quetiapine Fumarate
Antiemetics
Antiemetics Emetogenic Therapy Adjuncts
Antiemetics Netupitant/Palonosetron Hydrochloride New FDA Approved Drug, 10/10/14
Antiemetics Rolapitant New FDA Approved Drug, 9/1/15
Antiemetics
Antiemetics Dolasetron Mesylate
Antiemetics Granisetron Hydrochloride
Antiemetics Ondansetron Hydrochloride
Antiemetics Palonosetron Hydrochloride
Antiemetics
Antiemetics Aprepitant
Antiemetics
Antiemetics Dronabinol
Antiemetics Nabilone
Antiemetics Antiemetics, Other
Antiemetics Chlorpromazine Hydrochloride
Antiemetics Diphenhydramine Hydrochloride
Antiemetics Doxylamine Succinate/
Pyridoxine Hydrochloride
Antiemetics Hydroxyzine Pamoate
Antiemetics Meclizine Hydrochloride
Antiemetics Metoclopramide
Antiemetics Perphenazine
Antiemetics Prochlorperazine Edisylate
Antiemetics Maleate
Antiemetics Promethazine Hydrochloride
Antiemetics Scopolamine
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 7
USP Medicare Model Guidelines v7.0 Page 7 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
Antiemetics Trimethobenzamide Hydrochloride
Antifungals
Antifungals
Antifungals Naftifine Hydrochloride
Antifungals Terbinafine Hydrochloride
Antifungals
Antifungals Butoconazole Nitrate
Antifungals Clotrimazole
Antifungals Econazole Nitrate
Antifungals Efinaconazole New FDA Approved Drug, 6/6/14
Antifungals Fluconazole
Antifungals Isavuconazonium New FDA Approved Drug, 3/6/15
Antifungals Itraconazole
Antifungals Ketoconazole
Antifungals Luliconazole
Antifungals Miconazole Nitrate
Antifungals Oxiconazole Nitrate
Antifungals Posaconazole
Antifungals Sertaconazole Nitrate
Antifungals Sulconazole Nitrate
Antifungals Terconazole
Antifungals Voriconazole
Antifungals
Antifungals
Antifungals Anidulafungin
Antifungals Caspofungin Acetate
Antifungals Micafungin Sodium
Antifungals
Antifungals Natamycin
Antifungals Nystatin
Antifungals
Antifungals Butenafine Hydrochloride
Antifungals Ciclopirox
Antifungals Flucytosine
Antifungals Griseofulvin
Antifungals Tavaborole New FDA Approved Drug, 7/7/14
Antigout Agents
Antigout Agents
Antigout Agents Probenecid
Antigout Agents
Antigout Agents Allopurinol
Antigout Agents Febuxostat
Antigout Agents
Antigout Agents Colchicine
Antigout Agents
Antigout Agents Lesinurad New FDA Approved Drug, 12/22/15
Anti-inflammatory Agents
Anti-inflammatory Agents Glucocorticoids
Anti-inflammatory Agents Nonsteroidal Anti-inflammatory Drugs
Anti-inflammatory Agents Celecoxib
Anti-inflammatory Agents Diclofenac Potassium
Anti-inflammatory Agents Diflunisal
Anti-inflammatory Agents Etodolac
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 8
USP Medicare Model Guidelines v7.0 Page 8 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
Anti-inflammatory Agents Fenoprofen Calcium
Anti-inflammatory Agents Flurbiprofen
Anti-inflammatory Agents Ibuprofen
Anti-inflammatory Agents Indomethacin
Anti-inflammatory Agents Ketoprofen
Anti-inflammatory Agents Ketorolac Tromethamine
Anti-inflammatory Agents Meclofenamate Sodium
Anti-inflammatory Agents Mefenamic Acid
Anti-inflammatory Agents Meloxicam
Anti-inflammatory Agents Nabumetone
Anti-inflammatory Agents Naproxen Sodium
Anti-inflammatory Agents Oxaprozin
Anti-inflammatory Agents Piroxicam
Anti-inflammatory Agents Sulindac
Anti-inflammatory Agents Tolmetin Sodium
Antimigraine Agents
Antimigraine Agents Ergot Alkaloids
Antimigraine Agents Dihydroergotamine Mesylate
Antimigraine Agents Ergotamine Tartrate
Antimigraine Agents Serotonin (5-HT) 1b/1d Receptor Agonists
Antimigraine Agents Almotriptan Malate
Antimigraine Agents Eletriptan
Antimigraine Agents Frovatriptan Succinate
Antimigraine Agents Naratriptan Hydrochloride
Antimigraine Agents Rizatriptan Benzoate
Antimigraine Agents Sumatriptan
Antimigraine Agents Zolmitriptan
Antimigraine Agents Prophylactic
Antimigraine Agents
Antimigraine Agents Timolol Maleate
Antimigraine Agents
Antimigraine Agents Divalproex Sodium
Antimigraine Agents Topiramate
Antimigraine Agents Valproic Acid
Antimyasthenic Agents
Antimyasthenic Agents Parasympathomimetics
Antimyasthenic Agents Ambenonium Chloride Discontinued by manufacturer
Antimyasthenic Agents Guanidine Hydrochloride
Antimyasthenic Agents Pyridostigmine Bromide
Antimycobacterials
Antimycobacterials Antituberculars
Antimycobacterials Bedaquiline Fumerate
Antimycobacterials Capreomycin Sulfate
Antimycobacterials Cycloserine
Antimycobacterials Ethambutol Hydrochloride
Antimycobacterials Ethionamide
Antimycobacterials Isoniazid
Antimycobacterials Pyrazinamide
Antimycobacterials Rifampin
Antimycobacterials Rifampin/Isoniazid
Antimycobacterials Rifampin/Isoniazid/
Pyrazinamide
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 9
USP Medicare Model Guidelines v7.0 Page 9 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
Antimycobacterials Rifapentine
Antimycobacterials Antimycobacterials, Other
Antimycobacterials Dapsone
Antimycobacterials Rifabutin
Antineoplastics
Antineoplastics Alkylating Agents
Antineoplastics
Antineoplastics Altretamine
Antineoplastics
Antineoplastics Chlorambucil
Antineoplastics Mechlorethamine hydrochloride
Antineoplastics Melphalan
Antineoplastics
Antineoplastics Lomustine
Antineoplastics
Antineoplastics Busulfan
Antineoplastics Cyclophosphamide
Antineoplastics Procarbazine Hydrochloride
Antineoplastics Trabectedin New FDA approved drug, 10/23/15
Antineoplastics Antiandrogens
Antineoplastics
Antineoplastics Enzalutamide
Antineoplastics Bicalutamide
Antineoplastics Flutamide
Antineoplastics Nilutamide
Antineoplastics
Antineoplastics Abiraterone Acetate
Antineoplastics Antiangiogenic Agents
Antineoplastics Lenalidomide
Antineoplastics Pomalidomide
Antineoplastics Thalidomide
Antineoplastics Antiestrogens/Modifiers
Antineoplastics
Antineoplastics Estramustine Phosphate
Sodium
Antineoplastics
Antineoplastics Tamoxifen Citrate
Antineoplastics Toremifene Citrate
Antineoplastics Antimetabolites
Antineoplastics
Antineoplastics Mercaptopurine
Antineoplastics Thioguanine
Antineoplastics
Antineoplastics Hydroxyurea
Antineoplastics Aromatase Inhibitors, 3rd Generation
Antineoplastics Anastrozole
Antineoplastics Exemestane
Antineoplastics Letrozole
Antineoplastics Enzyme Inhibitors
Antineoplastics Etoposide
Antineoplastics Topotecan
Antineoplastics Molecular Target Inhibitors
Antineoplastics Gefitinib New FDA approved drug, 7/13/15
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 10
USP Medicare Model Guidelines v7.0 Page 10 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
Antineoplastics
Antineoplastics Cobimetinib New FDA Approved Drug, 11/10/15
Antineoplastics
Antineoplastics Alectinib New FDA Approved Drug, 12/11/15
Antineoplastics Ceritinib New FDA Approved Drug, 4/28/14
Antineoplastics Crizotinib
Antineoplastics
Antineoplastics Vemurafenib
Antineoplastics Dabrafenib
Antineoplastics Trametinib
Antineoplastics
Antineoplastics Ibrutinib
Antineoplastics
Antineoplastics Palbociclib New FDA Approved Drug, 2/3/15
Antineoplastics
Antineoplastics Ramucirumab New FDA Approved Drug, 4/24/15
Antineoplastics
Antineoplastics Afatinib Dimaleate
Antineoplastics Erlotinib Hydrochloride
Antineoplastics Osimertinib New FDA Approved Drug, 11/13/15
Antineoplastics
Antineoplastics Sonidegib New FDA Approved Drug, 7/24/15
Antineoplastics Vismodegib
Antineoplastics
Antineoplastics Ruxolitinib
Antineoplastics
Antineoplastics Cabazitaxel Part D eligibile drug (CY16 FRF v09.26.16)
Antineoplastics
Antineoplastics Everolimus
Antineoplastics
Antineoplastics Bosutinib
Antineoplastics Dasatinib
Antineoplastics Imatinib Mesylate
Antineoplastics Nilotinib
Antineoplastics Ponatinib Hydrochloride
Antineoplastics
Antineoplastics Lapatinib
Antineoplastics
Antineoplastics Axitinib
Antineoplastics Cabozantinib Updated nomenclature to include salt
Antineoplastics Cabozantinib S-Malate Updated nomenclature to include salt
Antineoplastics Lenvatinib New FDA Approved Drug, 2/13/15
Antineoplastics Pazopanib
Antineoplastics Regorafenib
Antineoplastics Sorafenib Tosylate
Antineoplastics Sunitinib Malate
Antineoplastics Vandetanib
Antineoplastics
Antineoplastics Idelalisib New FDA Approved Drug, 7/23/14
Antineoplastics
Antineoplastics Olaparib New FDA Approved Drug, 12/19/14
Antineoplastics
Antineoplastics Venetoclax New FDA Approved Drug, 4/11/16
Antineoplastics
Antineoplastics Belinostat New FDA Approved Drug, 7/3/14
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 11
USP Medicare Model Guidelines v7.0 Page 11 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
Antineoplastics Panobinostat New FDA Approved Drug, 2/23/15
Antineoplastics Monoclonal Antibodies Monoclonal
Antibody/Antibody-Drug Conjugate
Nomenclature change; Renamed class to
reflect inclusion of Antibbody-Drug Conjugate
drugs
Antineoplastics Elotuzumab New FDA Approved Drug, 11/30/15
Antineoplastics
Antineoplastics Olaratumab New FDA Approved Drug, 10/19/2016
Antineoplastics
Antineoplastics Atezolizumab New FDA Approved Drug, 5/18/16
Antineoplastics Nivolumab New FDA Approved Drug, 12/22/14
Antineoplastics
Antineoplastics Rituximab
Antineoplastics Ofatumumab
Antineoplastics Retinoids
Antineoplastics Alitretinoin
Antineoplastics Bexarotene
Antineoplastics Tretinoin
Antineoplastics Treatment Adjuncts New class to reflect therapeutics
Antineoplastics Allopurinol Additional Classification; drug added to new
class
Antineoplastics Mesna Part D eligible drug (CY16 FRF v09.26.16)
Antineoplastics Rasburicase Part D eligible drug (CY16 FRF v09.26.16)
Antineoplastics Antineoplastics, Other
Antineoplastics Fludarabine
Antineoplastics Ixazomib New FDA Approved Drug, 11/20/15
Antineoplastics Leucovorin
Antineoplastics Mitoxantrone Hydrochloride
Antineoplastics Pegaspargase Part D eligibile drug (CY16 FRF v09.26.16)
Antineoplastics Tiperacil/Trifluridine New FDA Approved Drug, 09/22/15
Antineoplastics Vorinostat
Antiparasitics
Antiparasitics Anthelmintics
Antiparasitics Albendazole
Antiparasitics Ivermectin
Antiparasitics Mebendazole
Antiparasitics Praziquantel
Antiparasitics Antiprotozoals
Antiparasitics
Antiparasitics Miltefosine New FDA Approved Drug, 3/19/14
Antiparasitics
Antiparasitics Artemether/Lumefantrine
Antiparasitics Atovaquone/Proguanil
Hydrochloride
Antiparasitics Chloroquine Phosphate
Antiparasitics Hydroxychloroquine Sulfate
Antiparasitics Mefloquine Hydrochloride
Antiparasitics Primaquine Phosphate
Antiparasitics Pyrimethamine
Antiparasitics Quinine Sulfate
Antiparasitics
Antiparasitics Atovaquone
Antiparasitics Nitazoxanide
Antiparasitics Pentamidine Isethionate
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 12
USP Medicare Model Guidelines v7.0 Page 12 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
Antiparasitics Pediculicides/Scabicides
Antiparasitics Benzyl alcohol
Antiparasitics Crotamiton
Antiparasitics Lindane
Antiparasitics Malathion
Antiparasitics Permethrin
Antiparasitics Spinosad
Antiparkinson Agents
Antiparkinson Agents Anticholinergics
Antiparkinson Agents Benztropine Mesylate
Antiparkinson Agents Diphenhydramine Hydrochloride
Antiparkinson Agents Trihexyphenidyl Hydrochloride
Antiparkinson Agents Dopamine Agonists
Antiparkinson Agents Apomorphine Hydrochloride
Antiparkinson Agents Bromocriptine Mesylate
Antiparkinson Agents Pramipexole Dihydrochloride
Monohydrate
Antiparkinson Agents Ropinirole Hydrochloride
Antiparkinson Agents Rotigotine
Antiparkinson Agents Dopamine Precursors/ L-Amino Acid
Decarboxylase Inhibitors
Antiparkinson Agents Carbidopa
Antiparkinson Agents Carbidopa/Levodopa
Antiparkinson Agents Monoamine Oxidase B (MAO-B) Inhibitors
Antiparkinson Agents Rasagiline Mesylate
Antiparkinson Agents Selegiline Hydrochloride
Antiparkinson Agents Antiparkinson Agents, Other
Antiparkinson Agents
Antiparkinson Agents Entacapone
Antiparkinson Agents Tolcapone
Antiparkinson Agents
Antiparkinson Agents Amantadine Hydrochloride
Antipsychotics
Antipsychotics 1st Generation/Typical
Antipsychotics Chlorpromazine Hydrochloride
Antipsychotics Fluphenazine Hydrochloride
Antipsychotics Haloperidol Lactate
Antipsychotics Loxapine Succinate
Antipsychotics Perphenazine
Antipsychotics Pimozide
Antipsychotics Prochlorperazine Edisylate
Antipsychotics Prochlorperazine Maleate
Antipsychotics Thioridazine Hydrochloride
Antipsychotics Thiothixene Hydrochloride
Antipsychotics Trifluoperazine Hydrochloride
Antipsychotics 2nd Generation/Atypical
Antipsychotics Aripiprazole
Antipsychotics Asenapine
Antipsychotics Brexipiprazole New FDA Approved Drug, 7/10/15
Antipsychotics Cariprazine New FDA Approved Drug, 9/17/15
Antipsychotics Iloperidone
Antipsychotics Lurasidone
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 13
USP Medicare Model Guidelines v7.0 Page 13 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
Antipsychotics Olanzapine
Antipsychotics Pimavanserin New FDA Approved Drug, 4/29/16
Antipsychotics Quetiapine Fumarate
Antipsychotics Paliperidone
Antipsychotics Risperidone
Antipsychotics Ziprasidone Hydrochloride
Antipsychotics Ziprasidone Mesylate
Antipsychotics Treatment-Resistant
Antipsychotics Clozapine
Antispasticity Agents
Antispasticity Agents Baclofen
Antispasticity Agents Dantrolene Sodium
Antispasticity Agents Tizanidine Hydrochloride
Antivirals
Antivirals Anti-cytomegalovirus (CMV) Agents
Antivirals Cidofovir
Antivirals Foscarnet Sodium
Antivirals Ganciclovir Sodium
Antivirals Valganciclovir Hydrochloride
Antivirals Anti-hepatitis B (HBV) Agents
Antivirals Adefovir Dipivoxil
Antivirals Entecavir
Antivirals Lamivudine
Antivirals Ribavirin
Antivirals Telbivudine
Antivirals Tenofovir Disoproxil
Fumarate
Antivirals
Antivirals Interferon Alfa-2b,
Recombinant
Antivirals Interferon Alfa-2b/Ribavirin
Antivirals Interferon Alfa-n3
Antivirals Peginterferon Alfa-2a
Antivirals Peginterferon Alfa-2b
Anti-hepatitis C (HCV) Agents, Direct
Acting
New class to reflect therapeutics
Antivirals
Antivirals Boceprevir Discontinued by manufacturer
Antivirals Simeprevir
Antivirals Telaprevir Discontinued by manufacturer
Antivirals
Antivirals Daclatasvir New FDA Approved Drug, 7/24/15
Antivirals Sofosbuvir
Antivirals
Antivirals Elbasvir/Grazoprevir New FDA Approved Drug, 1/28/16
Antivirals Ledipasvir/Sofosbuvir New FDA Approved Drug, 10/10/14
Antivirals Ombitasvir/Paritaprevir/
Ritonavir/Dasabuvir
New FDA Approved Drug, 12/19/14
Antivirals Sofosbuvir/Velpatasvir New FDA Approved Drug, 6/28/16
Anti-hepatitis C (HCV) Agents Anti-
hepatitis C (HCV) Agents, Other
Nomenclature change; Renamed class to
reflect therapeutics
Ribavirin
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 14
USP Medicare Model Guidelines v7.0 Page 14 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
Interferon Alfa-2b,
Recombinant
Interferon Alfa-2b/Ribavirin
Interferon Alfa-n3
Interferon Alfacon-1
Peginterferon Alfa-2a
Peginterferon Alfa-2b
Antivirals Antiherpetic Agents
Antivirals Acyclovir
Antivirals Famciclovir
Antivirals Foscarnet Sodium
Antivirals Idoxuridine
Antivirals Trifluridine
Antivirals Penciclovir Sodium
Antivirals Valacyclovir Hydrochloride
Antivirals Anti-HIV Agents, Non-nucleoside Reverse
Transcriptase Inhibitors (NNRTI)
Antivirals Delavirdine Mesylate
Antivirals Efavirenz
Antivirals Etravirine
Antivirals Nevirapine
Antivirals Rilpivirine
Antivirals Efavirenz/ Emtricitabine/
Tenofovir disoproxil fumarate
Antivirals Emtricitabine/ Rilpivirine /
Tenofovir disoproxil fumerate
Antivirals Anti-HIV Agents, Nucleoside and
Nucleotide Reverse Transcriptase
Inhibitors (NRTI)
Antivirals Abacavir Sulfate
Antivirals Abacavir/Lamivudine
Antivirals Abacavir/ Lamivudine/
Zidovudine
Antivirals Didanosine
Antivirals
Antivirals Emtricitabine
Antivirals Emtricitabine/Tenofovir Disoproxil
Fumarate
Antivirals Lamivudine
Antivirals Lamivudine/Zidovudine
Antivirals Stavudine
Antivirals Tenofovir Disoproxil
Fumarate
Antivirals Zidovudine
Antivirals Anti-HIV Agents, Protease Inhibitors
Antivirals Atazanavir Sulfate
Antivirals Atazanavir/ Cobicistat New FDA Approved Drug, 1/29/15
Antivirals Darunavir Ethanolate
Antivirals Darunavir/Cobicistat New FDA Approved Drug, 1/29/15
Antivirals Fosamprenavir Calcium
Antivirals Indinavir Sulfate
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 15
USP Medicare Model Guidelines v7.0 Page 15 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
Antivirals Lopinavir/Ritonavir
Antivirals Nelfinavir Mesylate
Antivirals Ritonavir
Antivirals Saquinavir Mesylate
Antivirals Tipranavir
Antivirals Anti-HIV Agents, Integrase Inhibitors
(INSTI)
Antivirals Dolutegravir Sodium
Antivirals Elvitegravir/ Cobicistat/
Emtricitabine/ Tenofovir
disoproxil fumarate
Antivirals Elvitegravir/ Cobicistat/
Emtricitabine/ Tenofovir
alafenamide
New FDA Approved Drug, 11/5/15
Antivirals Raltegravir
Antivirals Anti-HIV Agents, Other
Antivirals Enfuvirtide
Antivirals Maraviroc
Antivirals Anti-influenza Agents
Antivirals Amantadine Hydrochloride
Antivirals Oseltamivir Phosphate
Antivirals Peramivir New FDA Approved Drug, 12/19/14
Antivirals Rimantadine Hydrochloride
Antivirals Zanamivir
Anxiolytics
Anxiolytics SSRIs/SNRIs (Selective Serotonin
Reuptake Inhibitors/ Serotonin and
Norepinephrine Reuptake Inhibitors)
Anxiolytics Duloxetine Hydrochloride
Anxiolytics Escitalopram Oxalate
Anxiolytics Paroxetine Hydrochloride
Anxiolytics Sertraline Hydrochloride
Anxiolytics Venlafaxine Hydrochloride
Anxiolytics Benzodiazepines
Anxiolytics Alprazolam
Anxiolytics Chlordiazepoxide
Anxiolytics Clonazepam
Anxiolytics Clorazepate Dipotassium
Anxiolytics Diazepam
Anxiolytics Lorazepam
Anxiolytics Oxazepam
Anxiolytics Anxiolytics, Other
Anxiolytics Buspirone Hydrochloride
Anxiolytics Doxepin Hydrochloride
Anxiolytics Hydroxyzine Hydrochloride
Anxiolytics Meprobamate
Bipolar Agents
Bipolar Agents Mood Stabilizers
Bipolar Agents Carbamazepine
Bipolar Agents Divalproex Sodium
Bipolar Agents Lamotrigine
Bipolar Agents Lithium Carbonate
Bipolar Agents Valproic Acid
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 16
USP Medicare Model Guidelines v7.0 Page 16 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
Bipolar Agents Bipolar Agents, Other
Bipolar Agents Aripiprazole
Bipolar Agents Asenapine
Bipolar Agents Olanzapine
Bipolar Agents Quetiapine Fumarate
Bipolar Agents Risperidone
Bipolar Agents Ziprasidone Hydrochloride
Bipolar Agents Ziprasidone Mesylate
Blood Glucose Regulators
Blood Glucose Regulators Antidiabetic Agents
Blood Glucose Regulators
Blood Glucose Regulators Acarbose
Blood Glucose Regulators Miglitol
Blood Glucose Regulators
Blood Glucose Regulators Pramlintide Acetate
Blood Glucose Regulators
Blood Glucose Regulators Metformin Hydrochloride
Blood Glucose Regulators
Blood Glucose Regulators Colesevelam Hydrochloride
Blood Glucose Regulators
Blood Glucose Regulators Alogliptin
Blood Glucose Regulators Linagliptin
Blood Glucose Regulators Saxagliptin
Blood Glucose Regulators Sitagliptin Phosphate
Blood Glucose Regulators
Blood Glucose Regulators Bromocriptine Mesylate
Blood Glucose Regulators
Blood Glucose Regulators Albiglutide New FDA Approved Drug, 4/15/14
Dulaglutide New FDA Approved Drug, 9/18/14
Blood Glucose Regulators Exenatide
Blood Glucose Regulators Liraglutide
Blood Glucose Regulators Lixisenatide New FDA Approved Drug, 7/27/16
Blood Glucose Regulators
Blood Glucose Regulators Nateglinide
Blood Glucose Regulators Repaglinide
Blood Glucose Regulators
Blood Glucose Regulators Canagliflozin
Blood Glucose Regulators Dapagliflozin New FDA Approved Drug, 1/8/14
Blood Glucose Regulators Empagliflozin New FDA Approved Drug, 8/1/14
Blood Glucose Regulators
Blood Glucose Regulators Chlorpropamide
Blood Glucose Regulators Glimepiride
Blood Glucose Regulators Glipizide
Blood Glucose Regulators Glyburide
Blood Glucose Regulators Tolazamide
Blood Glucose Regulators Tolbutamide
Blood Glucose Regulators
Blood Glucose Regulators Pioglitazone Hydrochloride
Blood Glucose Regulators Rosiglitazone Maleate
Blood Glucose Regulators Glycemic Agents
Blood Glucose Regulators Diazoxide
Blood Glucose Regulators Diazoxide
Blood Glucose Regulators Glucagon
Blood Glucose Regulators Insulins
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 17
USP Medicare Model Guidelines v7.0 Page 17 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
Blood Glucose Regulators
Blood Glucose Regulators Insulin Aspart
Blood Glucose Regulators Insulin Glulisine
Blood Glucose Regulators Insulin Lispro
Blood Glucose Regulators
Blood Glucose Regulators Insulin Human (Regular)
Blood Glucose Regulators
Blood Glucose Regulators Isophane Insulin (Human)
Blood Glucose Regulators
Blood Glucose Regulators Insulin Degludec New FDA Approved Drug, 9/25/15
Blood Glucose Regulators Insulin Detemir
Blood Glucose Regulators Insulin Glargine
Blood Glucose Regulators
Blood Glucose Regulators Insulin Aspart Rapid-acting/
Insulin Aspart Protamine
Blood Glucose Regulators Insulin Lispro Rapid-acting/
Insulin Lispro Protamine
Blood Glucose Regulators
Blood Glucose Regulators Insulin Human Regular/
Isophane Insulin
Blood Products/Modifiers/ Volume
Expanders
Blood Products Anticoagulants
Blood Products
Blood Products Dabigatran
Blood Products
Blood Products Apixaban
Blood Products Rivaroxaban
Blood Products Edoxaban New FDA Approved Drug, 1/8/15
Blood Products
Blood Products Fondaparinux Sodium
Blood Products
Blood Products
Blood Products Dalteparin Sodium
Blood Products Enoxaparin Sodium
Blood Products
Blood Products Vorapaxar New FDA Approved Drug, 5/8/14
Blood Products
Blood Products Warfarin Sodium
Blood Products Blood Formation Modifiers
Blood Products
Blood Products Azacitidine New FDA Approved Drug, 4/29/16
Blood Products
Blood Products Filgrastim
Blood Products Pegfilgrastim
Blood Products Sargramostim
Blood Products
Blood Products Darbepoetin Alfa
Blood Products Epoetin Alfa
Blood Products
Blood Products Anagrelide
Blood Products
Blood Products Eltrombopag Olamine
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 18
USP Medicare Model Guidelines v7.0 Page 18 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
Blood Products Romiplostim
Blood Products
Blood Products Plerixafor
Blood Products Coagulants
Hemostasis Agents
Nomenclature change; Renamed class to
reflect therapeutics
Blood Products
Blood Products Tranexamic Acid
Blood Products Platelet Modifying Agents
Blood Products
Blood Products Clopidogrel Bisulfate
Blood Products Prasugrel
Blood Products Ticlopidine Hydrochloride
Blood Products Ticagrelor
Blood Products
Blood Products Dipyridamole
Blood Products Dipyridamole/ Aspirin
Blood Products
Blood Products Cilostazol
Cardiovascular Agents
Cardiovascular Agents Alpha-adrenergic Agonists
Cardiovascular Agents Clonidine Hydrochloride
Cardiovascular Agents Droxidopa New FDA Approved Drug, 2/18/14
Cardiovascular Agents Guanfacine Hydrochloride
Cardiovascular Agents Methyldopa
Cardiovascular Agents Methyldopate Hydrochloride
Cardiovascular Agents Midodrine Hydrochloride
Cardiovascular Agents Phenylephrine Hydrochloride
Cardiovascular Agents Alpha-adrenergic Blocking Agents
Cardiovascular Agents Doxazosin Mesylate
Cardiovascular Agents Phenoxybenzamine Hydrochloride
Cardiovascular Agents Prazosin Hydrochloride
Cardiovascular Agents Terazosin Hydrochloride
Cardiovascular Agents Angiotensin-converting Enzyme (ACE)
Inhibitors
Cardiovascular Agents Benazepril Hydrochloride
Cardiovascular Agents Captopril
Cardiovascular Agents Enalapril Maleate
Cardiovascular Agents Fosinopril Sodium
Cardiovascular Agents Lisinopril
Cardiovascular Agents Moexipril Hydrochloride
Cardiovascular Agents Perindopril Erbumine
Cardiovascular Agents Quinapril Hydrochloride
Cardiovascular Agents Ramipril
Cardiovascular Agents Trandolapril
Cardiovascular Agents Angiotensin II Receptor Antagonists
Cardiovascular Agents Azilsartan Medoxomil
Cardiovascular Agents Candesartan Cilexetil
Cardiovascular Agents Eprosartan Mesylate
Cardiovascular Agents Irbesartan
Cardiovascular Agents Losartan Potassium
Cardiovascular Agents Olmesartan Medoxomil
Cardiovascular Agents Telmisartan
Cardiovascular Agents Valsartan
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 19
USP Medicare Model Guidelines v7.0 Page 19 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
Cardiovascular Agents Antiarrhythmics
Cardiovascular Agents Amiodarone Hydrochloride
Cardiovascular Agents Disopyramide Phosphate
Cardiovascular Agents Dofetilide
Cardiovascular Agents Dronedarone
Cardiovascular Agents Flecainide Acetate
Cardiovascular Agents Mexiletine Hydrochloride
Cardiovascular Agents Procainamide Hydrochloride
Cardiovascular Agents Propafenone Hydrochloride
Cardiovascular Agents Quinidine Hydrochloride
Cardiovascular Agents Sotalol Hydrochloride
Cardiovascular Agents Beta-adrenergic Blocking Agents
Cardiovascular Agents Acebutolol Hydrochloride
Cardiovascular Agents Atenolol
Cardiovascular Agents Betaxolol Hydrochloride
Cardiovascular Agents Bisoprolol Fumarate
Cardiovascular Agents Carvedilol Phosphate
Cardiovascular Agents Labetalol Hydrochloride
Cardiovascular Agents Metoprolol Succinate
Cardiovascular Agents Tartrate
Cardiovascular Agents Nadolol
Cardiovascular Agents Nebivolol
Cardiovascular Agents Penbutolol Sulfate Discontinued by manufacturer
Cardiovascular Agents Pindolol
Cardiovascular Agents Propranolol Hydrochloride
Cardiovascular Agents Timolol Maleate
Cardiovascular Agents Calcium Channel Blocking Agents
Cardiovascular Agents
Cardiovascular Agents Amlodipine
Cardiovascular Agents Felodipine
Cardiovascular Agents Isradipine
Cardiovascular Agents Nicardipine Hydrochloride
Cardiovascular Agents Nifedipine
Cardiovascular Agents Nimodipine
Cardiovascular Agents Nisoldipine
Cardiovascular Agents
Cardiovascular Agents Diltiazem Hydrochloride
Cardiovascular Agents Verapamil Hydrochloride
Cardiovascular Agents
Cardiovascular Agents Diuretics, Carbonic Anhydrase Inhibitors
Cardiovascular Agents Acetazolamide Sodium
Cardiovascular Agents Methazolamide
Cardiovascular Agents Diuretics, Loop
Cardiovascular Agents Bumetanide
Cardiovascular Agents Ethacrynate Sodium
Cardiovascular Agents Ethacrynic Acid
Cardiovascular Agents Furosemide
Cardiovascular Agents Torsemide
Cardiovascular Agents Diuretics, Potassium-sparing
Cardiovascular Agents Amiloride Hydrochloride
Cardiovascular Agents Eplerenone
Cardiovascular Agents Spironolactone
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 20
USP Medicare Model Guidelines v7.0 Page 20 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
1001
1002
1003
1004
1005
1006
Cardiovascular Agents Triamterene
Cardiovascular Agents Diuretics, Thiazide
Cardiovascular Agents Bendroflumethiazide
Cardiovascular Agents Chlorothiazide Sodium
Cardiovascular Agents Chlorthalidone
Cardiovascular Agents Hydrochlorothiazide
Cardiovascular Agents Indapamide
Cardiovascular Agents Methyclothiazide
Cardiovascular Agents Metolazone
Cardiovascular Agents Dyslipidemics, Fibric Acid Derivatives
Cardiovascular Agents Choline Fenofibrate
Cardiovascular Agents Fenofibrate
Cardiovascular Agents Fenofibric Acid
Cardiovascular Agents Gemfibrozil
Cardiovascular Agents Dyslipidemics, HMG CoA Reductase
Inhibitors
Cardiovascular Agents Atorvastatin Calcium
Cardiovascular Agents Fluvastatin Sodium
Cardiovascular Agents Lovastatin
Cardiovascular Agents Pitavastatin
Cardiovascular Agents Pravastatin Sodium
Cardiovascular Agents Rosuvastatin Calcium
Cardiovascular Agents Simvastatin
Cardiovascular Agents Dyslipidemics, Other
Cardiovascular Agents Cholestyramine
Cardiovascular Agents Colesevelam Hydrochloride
Cardiovascular Agents Colestipol Hydrochloride
Cardiovascular Agents Ezetimibe
Cardiovascular Agents Icosapent ethyl
Cardiovascular Agents Lomitapide Mesylate
Cardiovascular Agents Mipomersen Sodium
Cardiovascular Agents Niacin
Cardiovascular Agents Omega-3-acid Ethyl Esters
Cardiovascular Agents
Cardiovascular Agents Alirocumab New FDA Approved Drug, 7/24/15
Cardiovascular Agents Evolocumab New FDA Approved Drug, 8/27/15
Cardiovascular Agents Vasodilators, Direct-acting Arterial
Cardiovascular Agents Hydralazine Hydrochloride
Cardiovascular Agents Minoxidil
Cardiovascular Agents Vasodilators, Direct-acting Arterial/Venous
Cardiovascular Agents Isosorbide Dinitrate
Cardiovascular Agents Isosorbide Mononitrate
Cardiovascular Agents Nitroglycerin
Cardiovascular Agents Cardiovascular Agents, Other
Cardiovascular Agents Aliskiren
Cardiovascular Agents Digoxin
Cardiovascular Agents Ivabradine New FDA Approved Drug, 4/15/15
Cardiovascular Agents Pentoxifylline
Cardiovascular Agents Ranolazine
Cardiovascular Agents Sacubitril/Valsartan New FDA Approved Drug, 7/7/15
Central Nervous System Agents
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 21
USP Medicare Model Guidelines v7.0 Page 21 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1007
1008
1009
1010
1011
1012
1013
1014
1015
1016
1017
1018
1019
1020
1021
1022
1023
1024
1025
1026
1027
1028
1029
1030
1031
1032
1033
1034
1035
1036
1037
1038
1039
1040
1041
1042
1043
1044
1045
1046
1047
1048
1049
1050
1051
1052
1053
1054
1055
Central Nervous System Agents Attention Deficit Hyperactivity Disorder
Agents, Amphetamines
Central Nervous System Agents Dextroamphetamine Sulfate
Central Nervous System Agents Dextroamphetamine/
Amphetamine
Mixed Salts
Central Nervous System Agents Lisdexamfetamine
Central Nervous System Agents Methamphetamine Hydrochloride
Central Nervous System Agents Attention Deficit Hyperactivity Disorder
Agents, Non-amphetamines
Central Nervous System Agents Atomoxetine Hydrochloride
Central Nervous System Agents Clonidine Hydrochloride
Central Nervous System Agents Dexmethylphenidate Hydrochloride
Central Nervous System Agents Guanfacine Hydrochloride
Central Nervous System Agents Methylphenidate Hydrochloride
Central Nervous System Agents Fibromyalgia Agents
Central Nervous System Agents Duloxetine Hydrochloride
Central Nervous System Agents Milnacipran
Central Nervous System Agents Pregabalin
Central Nervous System Agents Multiple Sclerosis Agents
Central Nervous System Agents
Central Nervous System Agents Interferon Beta-1a
Central Nervous System Agents Interferon Beta-1b
Central Nervous System Agents
Central Nervous System Agents Dalfampridine
Central Nervous System Agents
Central Nervous System Agents Teriflunomide
Central Nervous System Agents
Central Nervous System Agents Fingolimod
Central Nervous System Agents
Central Nervous System Agents Dimethyl fumarate
Central Nervous System Agents Glatiramer Acetate
Central Nervous System Agents Mitoxantrone Hydrochloride
Central Nervous System Agents Peginterferon Beta 1A New FDA Approved Drug, 8/15/14
Central Nervous System Agents Natalizumab
Central Nervous System Agents Daclizumab New FDA Approved Drug, 5/27/16
Central Nervous System Agents Central Nervous System, Other
Central Nervous System Agents Gabapentin enacarbil
Central Nervous System Agents
Central Nervous System Agents Tetrabenazine
Central Nervous System Agents Riluzole
Central Nervous System Agents Dextromethorphan/ Quinidine
Dental and Oral Agents
Dental and Oral Agents Cevimeline Hydrochloride
Dental and Oral Agents Chlorhexidine Gluconate
Dental and Oral Agents Doxycycline Hyclate
Dental and Oral Agents Minocycline Hydrochloride
Dental and Oral Agents Palifermin
Dental and Oral Agents Pilocarpine Hydrochloride
Dental and Oral Agents Prilocaine Hydrochloride
Dental and Oral Agents Triamcinolone Acetonide
Dermatological Agents
Dermatological Agents
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 22
USP Medicare Model Guidelines v7.0 Page 22 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1056
1057
1058
1059
1060
1061
1062
1063
1064
1065
1066
1067
1068
1069
1070
1071
1072
1073
1074
1075
1076
1077
1078
1079
1080
1081
1082
1083
1084
1085
1086
1087
1088
1089
1090
1091
1092
1093
1094
1095
1096
1097
1098
1099
1100
1101
1102
1103
1104
1105
Dermatological Agents Isotretinoin
Dermatological Agents
Dermatological Agents Adapalene
Dermatological Agents Azelaic Acid
Dermatological Agents Benzoyl Peroxide
Dermatological Agents Dapsone
Dermatological Agents Tazarotene
Dermatological Agents
Dermatological Agents Doxycycline Calcium
Dermatological Agents Hyclate
Dermatological Agents
Dermatological Agents Doxepin Hydrochloride
Dermatological Agents
Dermatological Agents Pimecrolimus
Dermatological Agents Tacrolimus
Dermatological Agents
Dermatological Agents Podofilox
Dermatological Agents
Dermatological Agents Ammonium Lactate
Dermatological Agents
Dermatological Agents Imiquimod
Dermatological Agents Sinecatechins
Dermatological Agents
Dermatological Agents Selenium Sulfide
Dermatological Agents
Dermatological Agents Diclofenac Sodium
Dermatological Agents Fluorouracil
Dermatological Agents Imiquimod
Dermatological Agents Ingenol mebutate
Dermatological Agents
Dermatological Agents Methoxsalen
Dermatological Agents
Dermatological Agents Acitretin
Dermatological Agents Calcitriol
Dermatological Agents Ustekinumab
Dermatological Agents Secukinumab New FDA Approved Drug, 1/21/15
Dermatological Agents Ixekizumab New FDA Approved Drug, 3/22/16
Dermatological Agents
Dermatological Agents Calcipotriene
Dermatological Agents
Dermatological Agents Becaplermin
Dermatological Agents Collagenase
Dermatological Agents
Dermatological Agents Brimonidine Tartrate
Therapeutic Nutrients/ Minerals/
Electrolytes Electrolytes/Minerals/
Metals/ Vitamins
Nomenclature change; Renamed category to
reflect therapeutics. Moved according to
alphabetization.
Electrolytes Electrolyte/Mineral Modifiers
Electrolyte/Mineral/Metal Modifiers
Nomenclature change; Renamed class to
reflect therapeutics
Electrolytes
Electrolytes Deferasirox
Electrolytes Deferiprone
Electrolytes
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 23
USP Medicare Model Guidelines v7.0 Page 23 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1106
1107
1108
1109
1110
1111
1112
1113
1114
1115
1116
1117
1118
1119
1120
1121
1122
1123
1124
1125
1126
1127
1128
1129
1130
1131
1132
1133
1134
1135
1136
1137
1138
1139
1140
1141
1142
1143
1144
1145
1146
1147
1148
1149
Patiromer Sorbitex Calcium New FDA Approved Drug, 10/21/15
Electrolytes Penicillamine
Electrolytes Sodium Polystyrene
Sulfonate
Electrolytes Succimer
Electrolytes Tolvaptan
Electrolytes Trientine Hydrochloride
Electrolytes
Electrolytes Electrolyte/Mineral Replacement
Electrolytes Ammonium Chloride
Electrolytes Carglumic Acid
Electrolytes Chromic Chloride
Electrolytes Citric Acid/ Potassium
Citrate/ Sodium Citrate
Electrolytes Fluoride Sodium
Electrolytes Stannous
Electrolytes Magnesium Chloride
Electrolytes Sulfate
Electrolytes Manganese Chloride
Electrolytes Potassium Acetate
Electrolytes Bicarbonate
Electrolytes Chloride
Electrolytes Citrate
Electrolytes Gluconate
Electrolytes Phosphates
Electrolytes Potassium Bicarbonate/
Potassium Citrate
Electrolytes Potassium Citrate/ Citric Acid
Electrolytes Potassium Citrate/ Sodium
Citrate
Electrolytes Potassium Gluconate/
Potassium Chloride
Electrolytes Potassium Gluconate/
Potassium Citrate
Electrolytes Potassium Phosphate/
Sodium Phosphate
Electrolytes Selenium
Electrolytes Sodium Acetate
Electrolytes Sodium Bicarbonate
Electrolytes Sodium Lactate
Electrolytes Sodium Chloride
Electrolytes Sodium Ferric Gluconate
Complex
Electrolytes Sodium Phosphates
Electrolytes Phosphate Binders Class moved from USP Category
Genitourinary Agents
Electrolytes Calcium Acetate
Electrolytes Ferric Citrate New FDA Approved Drug, 9/5/14
Electrolytes Lanthanum Carbonate
Electrolytes Sevelamer Hydrochloride
Electrolytes Sucroferric Oxyhydroxide
Electrolytes Vitamins
Prenatal Part D eligibile drug (CY16 FRF v09.26.16)
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 24
USP Medicare Model Guidelines v7.0 Page 24 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1150
1151
1152
1153
1154
1155
1156
1157
1158
1159
1160
1161
1162
1163
1164
1165
1166
1167
1168
1169
1170
1171
1172
1173
1174
1175
1176
1177
1178
1179
1180
1181
1182
1183
1184
1185
1186
1187
1188
1189
1190
1191
1192
1193
1194
1195
1196
Gastrointestinal Agents
Gastrointestinal Agents Antispasmodics, Gastrointestinal
Gastrointestinal Agents Atropine Sulfate
Gastrointestinal Agents Dicyclomine Hydrochloride
Gastrointestinal Agents Glycopyrrolate
Gastrointestinal Agents Mepenzolate Bromide
Gastrointestinal Agents Methscopolamine Bromide
Gastrointestinal Agents Scopolamine
Gastrointestinal Agents Histamine2 (H2) Receptor Antagonists
Gastrointestinal Agents Cimetidine Hydrochloride
Gastrointestinal Agents Famotidine
Gastrointestinal Agents Nizatidine
Gastrointestinal Agents Ranitidine Hydrochloride
Gastrointestinal Agents Irritable Bowel Syndrome Agents
Gastrointestinal Agents
Gastrointestinal Agents Eluxadoline New FDA Approved Drug, 5/27/15
Gastrointestinal Agents Rifaximin New FDA Approved Drug, 3/24/10
Gastrointestinal Agents Alosetron Hydrochloride
Gastrointestinal Agents
Gastrointestinal Agents Linaclotide
Gastrointestinal Agents Lubiprostone
Gastrointestinal Agents Laxatives
Gastrointestinal Agents Lactulose
Gastrointestinal Agents Polyethylene Glycol 3350 NF
Gastrointestinal Agents Sodium picosulfate/
magnesium oxide/ citric acid
Gastrointestinal Agents Protectants
Gastrointestinal Agents Misoprostol
Gastrointestinal Agents Sucralfate
Gastrointestinal Agents Proton Pump Inhibitors
Gastrointestinal Agents Dexlansoprazole
Gastrointestinal Agents Esomeprazole Magnesium
Gastrointestinal Agents Lansoprazole
Gastrointestinal Agents Omeprazole
Gastrointestinal Agents Pantoprazole Sodium
Gastrointestinal Agents Rabeprazole Sodium
Gastrointestinal Agents Gastrointestinal Agents, Other
Gastrointestinal Agents Alvimopan
Gastrointestinal Agents Crofelemer
Gastrointestinal Agents Difenoxin Hydrochloride/
Atropine Sulfate
Gastrointestinal Agents Diphenoxylate Hydrochloride/
Atropine Sulfate
Gastrointestinal Agents Loperamide Hydrochloride
Gastrointestinal Agents Methylnaltrexone
Gastrointestinal Agents Metoclopramide
Gastrointestinal Agents Metreleptin New FDA Approved Drug, 2/24/14
Gastrointestinal Agents Rifaximin
Gastrointestinal Agents Ursodiol
Gastrointestinal Agents Naloxegol New FDA Approved Drug, 9/16/14
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 25
USP Medicare Model Guidelines v7.0 Page 25 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1197
1198
1199
1200
1201
1202
1203
1204
1205
1206
1207
1208
1209
1210
1211
1212
1213
1214
1215
1216
1217
1218
1219
1220
1221
1222
1223
1224
1225
1226
1227
1228
1229
1230
1231
1232
1233
1234
1235
1236
1237
1238
1239
1240
1241
1242
1243
1244
1245
Gastrointestinal Agents
Gastrointestinal Agents Glutamine
Gastrointestinal Agents Somatropin
Enzyme Replacement/Modifiers
Genetic or Enzyme Disorder:
Replacement, Modifiers, Treatment
Nomenclature change; Renamed to reflect
therapeutics. Moved according to
alphabetization.
Genetic or Enzyme Alpha-1 Protinease Inhibitor,
Human
Reclassification; drug moved from the class,
"Respiratory Tract Agents, Other," due to
therapeutics.
Genetic or Enzyme
Genetic or Enzyme Cholic Acid New FDA Approved drug, 3/17/15
Genetic or Enzyme
Genetic or Enzyme
Genetic or Enzyme Cysteamine Bitartrate
Genetic or Enzyme
Genetic or Enzyme Eteplirsen New FDA Approved Drug, 9/19/16
Genetic or Enzyme
Genetic or Enzyme Agalsidase Beta
Genetic or Enzyme
Genetic or Enzyme Alglucerase
Genetic or Enzyme Imiglucerase
Genetic or Enzyme Taliglucerase alfa
Genetic or Enzyme Velaglucerase alfa
Genetic or Enzyme
Genetic or Enzyme Eliglustat New FDA Approved Drug, 8/19/14
Genetic or Enzyme Miglustat
Genetic or Enzyme
Genetic or Enzyme Nitisinone
Genetic or Enzyme
Genetic or Enzyme Betaine Anhydrous
Genetic or Enzyme
Genetic or Enzyme Idursulfase
Genetic or Enzyme
Genetic or Enzyme Asfotase Alfa New FDA Approved Drug,10/23/15
Genetic or Enzyme
Genetic or Enzyme Sebelipase Alfa New FDA Approved Drug, 12/8/15
Genetic or Enzyme
Genetic or Enzyme Galsulfase
Genetic or Enzyme Laronidase
Genetic or Enzyme Elosulfase Alfa New FDA Approved Drug, 2/14/14
Genetic or Enzyme
Genetic or Enzyme Pancrelipase
Genetic or Enzyme
Genetic or Enzyme Sapropterin
Genetic or Enzyme
Genetic or Enzyme Pegademase Bovine
Genetic or Enzyme
Genetic or Enzyme Sacrosidase
Genetic or Enzyme
Genetic or Enzyme Sodium Phenylbutyrate
Genetic or Enzyme Glycerol Phenylbutyrate
Genetic or Enzyme Obeticholic Acid New FDA Approved Drug, 5/27/16
Genitourinary Agents
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 26
USP Medicare Model Guidelines v7.0 Page 26 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1246
1247
1248
1249
1250
1251
1252
1253
1254
1255
1256
1257
1258
1259
1260
1261
1262
1263
1264
1265
1266
1267
1268
1269
1270
1271
1272
1273
1274
1275
1276
1277
1278
1279
1280
1281
1282
1283
1284
1285
1286
1287
1288
1289
1290
1291
1292
Genitourinary Agents Antispasmodics, Urinary
Genitourinary Agents
Genitourinary Agents Mirabegron
Genitourinary Agents
Genitourinary Agents Darifenacin Hydrobromide
Genitourinary Agents Fesoterodine Fumarate
Genitourinary Agents Flavoxate Hydrochloride
Genitourinary Agents Oxybutynin Chloride
Genitourinary Agents Solifenacin Succinate
Genitourinary Agents Tolterodine Tartrate
Genitourinary Agents Trospium Chloride
Genitourinary Agents Benign Prostatic Hypertrophy Agents
Genitourinary Agents
Genitourinary Agents Alfuzosin Hydrochloride
Genitourinary Agents Doxazosin Mesylate
Genitourinary Agents Prazosin Hydrochloride
Genitourinary Agents Silodosin
Genitourinary Agents Tamsulosin Hydrochloride
Genitourinary Agents Terazosin Hydrochloride
Genitourinary Agents
Genitourinary Agents Dutasteride
Genitourinary Agents Finasteride
Genitourinary Agents
Genitourinary Agents Tadalafil
Genitourinary Agents Phosphate Binders Reclassification; class moved to the category,
Electrolytes/Minerals/Heavy Metals/
Vitamins."
Genitourinary Agents Calcium Acetate
Genitourinary Agents Lanthanum Carbonate
Genitourinary Agents Sevelamer Hydrochloride
Genitourinary Agents Sucroferric Oxyhydroxide
Genitourinary Agents Genitourinary Agents, Other
Genitourinary Agents Bethanechol
Genitourinary Agents Pencillamine
Genitourinary Agents Pentosan Polysulfate
Hormonal Agents, Stimulant/
Replacement/ Modifying (Adrenal)
Hormonal Agents
Hormonal Agents Corticotropin
Hormonal Agents
Hormonal Agents Betamethasone Sodium
Phosphate
Hormonal Agents Budesonide
Hormonal Agents Cortisone Acetate
Hormonal Agents Dexamethasone Acetate
Hormonal Agents Dexamethasone Sodium
Phosphate
Hormonal Agents Hydrocortisone Acetate
Hormonal Agents Hydrocortisone Sodium Succinate
Hormonal Agents Methylprednisolone Acetate
Hormonal Agents Methylprednisolone Sodium Succinate
Hormonal Agents Prednisolone Acetate
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 27
USP Medicare Model Guidelines v7.0 Page 27 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1293
1294
1295
1296
1297
1298
1299
1300
1301
1302
1303
1304
1305
1306
1307
1308
1309
1310
1311
1312
1313
1314
1315
1316
1317
1318
1319
1320
1321
1322
1323
1324
1325
1326
1327
1328
1329
1330
1331
1332
1333
1334
1335
1336
1337
1338
1339
1340
1341
Hormonal Agents Prednisolone Sodium
Phosphate
Hormonal Agents Prednisone
Hormonal Agents Triamcinolone Acetonide
Hormonal Agents Triamcinolone Diacetate
Hormonal Agents Triamcinolone Hexacetonide
Hormonal Agents
Hormonal Agents Alclometasone Dipropionate
Hormonal Agents Clocortolone Pivalate
Hormonal Agents Desonide
Hormonal Agents Dexamethasone Sodium
Phosphate
Hormonal Agents Hydrocortisone
Hormonal Agents
Hormonal Agents Betamethasone Valerate
Hormonal Agents Desoximetasone
Hormonal Agents Fluocinolone Acetonide
Hormonal Agents Flurandrenolide
Hormonal Agents Fluticasone Propionate
Hormonal Agents Hydrocortisone Butyrate
Hormonal Agents Probutate
Hormonal Agents Valerate
Hormonal Agents Mometasone Furoate
Hormonal Agents Prednicarbate
Hormonal Agents Triamcinolone Acetonide
Hormonal Agents
Hormonal Agents Amcinonide
Hormonal Agents Betamethasone Dipropionate
Hormonal Agents Desoximetasone
Hormonal Agents Diflorasone Diacetate
Hormonal Agents Fluocinolone Acetonide
Hormonal Agents Fluocinonide
Hormonal Agents Halcinonide
Hormonal Agents Triamcinolone Acetonide
Hormonal Agents
Hormonal Agents Betamethasone Dipropionate
Hormonal Agents Clobetasol Propionate
Hormonal Agents Diflorasone Diacetate
Hormonal Agents Halobetasol Propionate
Hormonal Agents
Hormonal Agents Fludrocortisone Acetate
Hormonal Agents,
Stimulant/Replacement/ Modifying
(Pituitary)
Hormonal Agents
Hormonal Agents Chorionic Gonadotropin
Hormonal Agents
Hormonal Agents Somatropin, Recombinant
Hormonal Agents Tesamorelin
Hormonal Agents
Hormonal Agents Mecasermin Rinfabate
Hormonal Agents
Hormonal Agents Desmopressin Acetate
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 28
USP Medicare Model Guidelines v7.0 Page 28 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1342
1343
1344
1345
1346
1347
1348
1349
1350
1351
1352
1353
1354
1355
1356
1357
1358
1359
1360
1361
1362
1363
1364
1365
1366
1367
1368
1369
1370
1371
1372
1373
1374
1375
1376
1377
1378
1379
1380
1381
1382
1383
1384
Hormonal Agents, Stimulant/
Replacement/ Modifying
(Prostaglandins)
Hormonal Agents Alprostadil
Hormonal Agents Carboprost Tromethamine
Hormonal Agents Misoprostol
Hormonal Agents, Stimulant/
Replacement/ Modifying (Sex
Hormones/ Modifiers)
Hormonal Agents Anabolic Steroids
Hormonal Agents Oxandrolone
Hormonal Agents Androgens
Hormonal Agents Danazol
Hormonal Agents Fluoxymesterone
Hormonal Agents Methyltestosterone
Hormonal Agents Testosterone Cypionate
Hormonal Agents Testosterone Enanthate
Hormonal Agents Testosterone Propionate
Hormonal Agents Estrogens
Hormonal Agents Estradiol Acetate
Hormonal Agents Estradiol Cypionate
Hormonal Agents Estradiol Hemihydrate
Hormonal Agents Estradiol Valerate
Hormonal Agents Estrogens, Conjugated
Hormonal Agents Estrogens, Conjugated
Synthetic
Hormonal Agents Estrogens, Esterified
Hormonal Agents Estrone Discontinued by manufacturer
Hormonal Agents Estropipate
Hormonal Agents Ethinyl Estradiol
Hormonal Agents Progesterone Agonists/Antagonists
Hormonal Agents Ulipristal
Hormonal Agents Progestins
Hormonal Agents Levonorgestrel
Hormonal Agents Medroxyprogesterone Acetate
Hormonal Agents Megestrol Acetate
Hormonal Agents Norethindrone Acetate
Hormonal Agents Norgestrel
Hormonal Agents Progesterone
Hormonal Agents Selective Estrogen Receptor Modifying
Agents
Hormonal Agents Raloxifene Hydrochloride
Hormonal Agents Ospemifene
Hormonal Agents Bazedoxifene/ conjugated
estrogens
Hormonal Agents,
Stimulant/Replacement/ Modifying
(Thyroid)
Hormonal Agents Levothyroxine Sodium
Hormonal Agents Liothyronine Sodium
Hormonal Agents Liotrix
Hormonal Agents, Suppressant
(Adrenal)
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 29
USP Medicare Model Guidelines v7.0 Page 29 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1385
1386
1387
1388
1389
1390
1391
1392
1393
1394
1395
1396
1397
1398
1399
1400
1401
1402
1403
1404
1405
1406
1407
1408
1409
1410
1411
1412
1413
1414
1415
1416
1417
1418
1419
1420
1421
1422
1423
1424
1425
1426
1427
1428
1429
1430
1431
Hormonal Agents Mitotane
Hormonal Agents, Suppressant
(Parathyroid)
Category removed to reflect therapeutics
Hormonal Agents Cinacalcet Hydrochloride Reclassification; drug moved to USP
Category, "Metabolic Bone Disease Agents."
Hormonal Agents, Suppressant
(Pituitary)
Hormonal Agents
Hormonal Agents Bromocriptine Mesylate
Hormonal Agents Cabergoline
Hormonal Agents
Hormonal Agents Leuprolide Acetate
Hormonal Agents Nafarelin Acetate
Hormonal Agents Triptorelin Pamoate
Hormonal Agents
Hormonal Agents Degarelix
Hormonal Agents
Hormonal Agents Pegvisomant
Hormonal Agents
Hormonal Agents Lanreotide
Hormonal Agents Octreotide
Hormonal Agents Pasireotide
Hormonal Agents, Suppressant
(Thyroid)
Hormonal Agents Antithyroid Agents
Hormonal Agents Methimazole
Hormonal Agents Propylthiouracil
Immunological Agents
Immunological Agents Angioedema (HAE) Agents Angioedema
Agents
Nomenclature Change; removed parenthetical
Immunological Agents
Immunological Agents Icatibant Acetate
Immunological Agents
Immunological Agents C1 esterase inhibitor
(human)
Immunological Agents Immune Suppressants
Immunological Agents
Immunological Agents Mycophenolic Acid
Immunological Agents
Immunological Agents Tacrolimus
Immunological Agents Cyclosporine
Immunological Agents
Immunological Agents Tofacitinib
Immunological Agents
Immunological Agents Sirolimus
Immunological Agents
Immunological Agents 6- Mercaptopurine
Immunological Agents Abatacept
Immunological Agents Anakinra
Immunological Agents Everolimus
Immunological Agents Methotrexate Sodium
Immunological Agents Penicillamine
Immunological Agents Pimecrolimus
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 30
USP Medicare Model Guidelines v7.0 Page 30 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1432
1433
1434
1435
1436
1437
1438
1439
1440
1441
1442
1443
1444
1445
1446
1447
1448
1449
1450
1451
1452
1453
1454
1455
1456
1457
1458
1459
1460
1461
1462
1463
1464
1465
1466
1467
1468
Immunological Agents
Immunological Agents
Immunological Agents Azathioprine
Immunological Agents
Immunological Agents Adalimumab
Immunological Agents Certolizumab Pegol
Immunological Agents Etanercept
Immunological Agents Golimumab
Immunological Agents Infliximab
Immunological Agents Immunizing Agents, Passive
Immunological Agents
Immunological Agents Anti-thymocyte Globulin
Immunological Agents Immune Globulin
Intramuscular (Human)
Immunological Agents Immune Globulin Intravenous
(Human)
Immunological Agents Immunomodulators
Immunological Agents
Immunological Agents Belimumab
Immunological Agents
Immunological Agents Interferon Gamma-1b,
Recombinant
Immunological Agents
Immunological Agents Canakinumab
Immunological Agents Rilonacept
Immunological Agents Siltuximab New FDA Approved Drug, 4/23/14
Immunological Agents Tocilizumab
Immunological Agents
Immunological Agents Auranofin
Immunological Agents Apremilast New FDA Approved Drug, 9/23/14
Immunological Agents Leflunomide
Immunological Agents Natalizumab
Immunological Agents Omalizumab Part D eligible drug (CY16 FRF v09.26.16)
Immunological Agents Vedolizumab New FDA Approved Drug, 5/20/14
Immunological Agents Vaccines
Immunological Agents
Immunological Agents Diphtheria and Tetanus
Toxoids Adsorbed (DT)
Immunological Agents Diphtheria and Tetanus
Toxoids and Acellular
Pertussis Vaccine Adsorbed
(DTaP)
Immunological Agents Diphtheria and Tetanus
Toxoids and Acellular
Pertussis Vaccine Adsorbed,
Hepatitis B (Recombinant)
and Inactivated Poliovirus
Vaccine
Immunological Agents Diphtheria and Tetanus
Toxoids and Acellular
Pertussis Absorbed and
Inactivated Poliovirus (DTaP-
IPV) Vaccine
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 31
USP Medicare Model Guidelines v7.0 Page 31 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1469
1470
1471
1472
1473
1474
1475
1476
1477
1478
1479
1480
1481
1482
1483
1484
1485
1486
1487
1488
1489
Immunological Agents Tetanus and Diphtheria
Toxoids Adsorbed for Adult
Use (Td)
Immunological Agents Tetanus Toxoid, Reduced
Diphtheria Toxoid and
Acellular Pertussis Vaccine,
Adsorbed (Tdap)
Immunological Agents
Immunological Agents Haemophilus B Conjugate
Vaccine
Immunological Agents Haemophilus B Conjugate
Vaccine and Hepatitis B
Vaccine (Recombinant)
Immunological Agents
Immunological Agents Hepatitis A Vaccine
Inactivated
Immunological Agents Hepatitis A Virus Vaccine
Inactivated and Hepatitis B
Virus Vaccine Recombinant
Immunological Agents
Immunological Agents Diphtheria and Tetanus
Toxoids and Acellular
Pertussis Vaccine Adsorbed,
Hepatitis B (Recombinant)
and Inactivated Poliovirus
Vaccine
Immunological Agents Haemophilus B Conjugate
Vaccine and Hepatitis B
Vaccine (Recombinant)
Immunological Agents Hepatitis B Virus Vaccine
Recombinant
Immunological Agents
Immunological Agents Japanese Encephalitis Virus
Vaccine Inactivated
Immunological Agents
Immunological Agents Measles Virus Vaccine Live
Immunological Agents Measles, Mumps, and
Rubella Virus Vaccine Live
Immunological Agents Measles, Mumps, Rubella,
and Varicella Virus Vaccine
Live
Immunological Agents
Immunological Agents Meningococcal
Oligosaccharide Diphtheria
CRM197 Conjugate Vaccine
Immunological Agents Meningococcal
Polysaccharide Vaccine
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 32
USP Medicare Model Guidelines v7.0 Page 32 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1490
1491
1492
1493
1494
1495
1496
1497
1498
1499
1500
1501
1502
1503
1504
1505
1506
1507
Immunological Agents Meningococcal
Polysaccharide Diphtheria
Toxoid Conjugate Vaccine
Immunological Agents
Immunological Agents Measles, Mumps, and
Rubella Virus Vaccine Live
Immunological Agents Measles, Mumps, Rubella,
and Varicella Virus Vaccine
Live
Immunological Agents
Immunological Agents Human Papillomavirus
Bivalent (type 16 and 18)
Vaccine Recombinant
Immunological Agents Human Papillomavirus
Quadrivalent (types 6, 11, 16
and 18) Vaccine
Recombinant
Immunological Agents
Immunological Agents Diphtheria and Tetanus
Toxoids and Acellular
Pertussis Vaccine Adsorbed
(DTaP)
Immunological Agents Diphtheria and Tetanus
Toxoids and Acellular
Pertussis Vaccine Adsorbed,
Hepatitis B (Recombinant)
and Inactivated Poliovirus
Immunological Agents Diphtheria and Tetanus
Toxoids and Acellular
Pertussis Absorbed and
Inactivated Poliovirus (DTaP-
IPV) Vaccine
Immunological Agents Tetanus Toxoid, Reduced
Diphtheria Toxoid, and
Acellular Pertussis Vaccine,
Adsorbed (Tdap)
Immunological Agents
Immunological Agents Diphtheria and Tetanus
Toxoids and Acellular
Pertussis Absorbed and
Inactivated Poliovirus (DTaP-
IPV) Vaccine
Immunological Agents Diphtheria and Tetanus
Toxoids and Acellular
Pertussis Vaccine Adsorbed,
Hepatitis B (Recombinant)
and Inactivated Poliovirus
Immunological Agents Poliovirus Vaccine
Inactivated
Immunological Agents
Immunological Agents Rabies Vaccine
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 33
USP Medicare Model Guidelines v7.0 Page 33 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1508
1509
1510
1511
1512
1513
1514
1515
1516
1517
1518
1519
1520
1521
1522
1523
1524
1525
1526
1527
1528
1529
1530
1531
1532
1533
1534
1535
Immunological Agents
Immunological Agents Rotavirus Vaccine Live
Immunological Agents
Immunological Agents Measles, Mumps, and
Rubella Virus Vaccine Live
Immunological Agents Measles, Mumps, Rubella,
and Varicella Virus Vaccine
Live
Immunological Agents Rubella Virus Vaccine
Immunological Agents
Immunological Agents Diphtheria and Tetanus
Toxoids Adsorbed (DT)
Immunological Agents Diphtheria and Tetanus
Toxoids and Acellular
Pertussis Vaccine Adsorbed
(DTaP)
Immunological Agents Diphtheria and Tetanus
Toxoids and Acellular
Pertussis Vaccine Adsorbed,
Hepatitis B (Recombinant)
and Inactivated Poliovirus
Vaccine
Immunological Agents Diphtheria and Tetanus
Toxoids and Acellular
Pertussis Absorbed and
Inactivated Poliovirus (DTaP-
IPV) Vaccine
Immunological Agents Tetanus and Diphtheria
Toxoids Adsorbed for Adult
Use (Td)
Immunological Agents Tetanus Toxoid
Immunological Agents Tetanus Toxoid Adsorbed
Immunological Agents Tetanus Toxoid, Reduced
Diphtheria Toxoid, and
Acellular Pertussis Vaccine,
Adsorbed (Tdap)
Immunological Agents
Immunological Agents Typhoid Vaccine Live Oral
Immunological Agents Typhoid Vi Polysaccharide
Vaccine
Immunological Agents
Immunological Agents Measles, Mumps, Rubella,
and Varicella Virus Vaccine
Live
Immunological Agents Meningococcal Group B
Vaccine
New FDA Approved Drug, 2/19/10
Immunological Agents Varicella Virus Vaccine
Immunological Agents
Immunological Agents Yellow Fever Vaccine
Immunological Agents
Immunological Agents Zoster Virus Vaccine Live
Inflammatory Bowel Disease Agents
Glucocorticoids
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 34
USP Medicare Model Guidelines v7.0 Page 34 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1536
1537
1538
1539
1540
1541
1542
1543
1544
1545
1546
1547
1548
1549
1550
1551
1552
1553
1554
1555
1556
1557
1558
1559
1560
1561
1562
1563
1564
1565
1566
1567
1568
1569
1570
1571
1572
1573
1574
1575
1576
1577
1578
1579
1580
1581
1582
1583
Betamethasone
Budesonide
Cortisone Acetate
Dexamethasone Acetate
Dexamethasone Sodium
Phosphate
Hydrocortisone Sodium Succinate
Methylprednisolone Acetate
Methylprednisolone Sodium Succinate
Prednisolone Acetate
Prednisolone Sodium Succinate
Prednisone
Triamcinolone Acetonide
Triamcinolone Diacetate
Aminosalicylates
Balsalazide Disodium
Mesalamine
Olsalazine Sodium
Sulfonamides
Sulfasalazine
Metabolic Bone Disease Agents
Metabolic Bone Disease Agents
Metabolic Bone Disease Agents Alendronate Sodium
Metabolic Bone Disease Agents Etidronate Disodium
Metabolic Bone Disease Agents Ibandronate Sodium
Metabolic Bone Disease Agents Risedronate Sodium
Metabolic Bone Disease Agents Tiludronate Disodium Discontinued by manufacturer
Metabolic Bone Disease Agents
Metabolic Bone Disease Agents Ibandronate Sodium
Metabolic Bone Disease Agents Pamidronate Disodium
Metabolic Bone Disease Agents Zoledronic Acid
Metabolic Bone Disease Agents
Metabolic Bone Disease Agents Calcitonin, Salmon
Metabolic Bone Disease Agents
Metabolic Bone Disease Agents Teriparatide
Metabolic Bone Disease Agents
Metabolic Bone Disease Agents Denosumab
Metabolic Bone Disease Agents
Metabolic Bone Disease Agents Calcifediol New FDA Approved Drug, 6/17/16
Metabolic Bone Disease Agents Calcitriol
Metabolic Bone Disease Agents Cinacalcet Reclassification; drug moved from Hormonal
Agents, Parathyroid category due to
therapeutics
Metabolic Bone Disease Agents Doxercalciferol
Parathyroid Hormone New FDA Approved Drug, 1/23/15
Metabolic Bone Disease Agents Paricalcitol
Ophthalmic Agents
Ophthalmic Agents Ophthalmic Anti-allergy Agents
Ophthalmic Agents Azelastine Hydrochloride
Ophthalmic Agents Bepotastine
Ophthalmic Agents Cromolyn Sodium
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 35
USP Medicare Model Guidelines v7.0 Page 35 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1584
1585
1586
1587
1588
1589
1590
1591
1592
1593
1594
1595
1596
1597
1598
1599
1600
1601
1602
1603
1604
1605
1606
1607
1608
1609
1610
1611
1612
1613
1614
1615
1616
1617
1618
1619
1620
1621
1622
1623
1624
1625
1626
1627
1628
1629
1630
1631
1632
1633
1634
1635
Ophthalmic Agents Emedastine Difumarate
Ophthalmic Agents Epinastine Hydrochloride
Ophthalmic Agents Lodoxamide Tromethamine
Ophthalmic Agents Nedocromil Sodium
Ophthalmic Agents Olopatadine Hydrochloride
Ophthalmic Agents Ophthalmic Antiglaucoma Agents
Ophthalmic Agents
Ophthalmic Agents Apraclonidine Hydrochloride
Ophthalmic Agents Brimonidine Tartrate
Ophthalmic Agents
Ophthalmic Agents Betaxolol Hydrochloride
Ophthalmic Agents Carteolol Hydrochloride
Ophthalmic Agents Levobunolol Hydrochloride
Ophthalmic Agents Metipranolol Hydrochloride
Ophthalmic Agents Timolol Hemihydrate
Ophthalmic Agents Timolol Maleate
Ophthalmic Agents
Ophthalmic Agents Acetazolamide
Ophthalmic Agents Brinzolamide
Ophthalmic Agents Dorzolamide Hydrochloride
Ophthalmic Agents Methazolamide
Ophthalmic Agents
Ophthalmic Agents Echothiophate Iodide
Ophthalmic Agents Pilocarpine Hydrochloride
Ophthalmic Agents Nitrate
Ophthalmic Agents Ophthalmic Anti-inflammatories
Ophthalmic Agents
Ophthalmic Agents Dexamethasone
Ophthalmic Agents Difluprednate
Ophthalmic Agents Fluorometholone Acetate
Ophthalmic Agents Loteprednol Etabonate
Ophthalmic Agents Prednisolone Acetate
Ophthalmic Agents Sodium
Phosphate
Ophthalmic Agents Rimexolone
Ophthalmic Agents
Ophthalmic Agents Bromfenac Sodium
Ophthalmic Agents Diclofenac Sodium
Ophthalmic Agents Flurbiprofen Sodium
Ophthalmic Agents Ketorolac Tromethamine
Ophthalmic Agents Nepafenac
Ophthalmic Agents Ophthalmic Prostaglandin and Prostamide
Analogs
Ophthalmic Agents Bimatoprost
Ophthalmic Agents Latanoprost
Ophthalmic Agents Tafluprost
Ophthalmic Agents Travoprost
Ophthalmic Agents Ophthalmic Agents, Other
Ophthalmic Agents Hydroxypropyl Cellulose
Ophthalmic Agents Naphazoline Hydrochloride Removed due to OTC status
Ophthalmic Agents Lifitegrast New FDA Approved Drug, 7/11/16
Ophthalmic Agents
Ophthalmic Agents Cyclosporine
Otic Agents
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 36
USP Medicare Model Guidelines v7.0 Page 36 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1636
1637
1638
1639
1640
1641
1642
1643
1644
1645
1646
1647
1648
1649
1650
1651
1652
1653
1654
1655
1656
1657
1658
1659
1660
1661
1662
1663
1664
1665
1666
1667
1668
1669
1670
1671
1672
1673
1674
1675
1676
1677
1678
1679
1680
1681
Otic Agents
Otic Agents Fluocinolone Acetonide
Respiratory Tract/ Pulmonary Agents
Antihistamines
Azelastine Hydrochloride
Cetirizine Hydrochloride
Desloratadine
Levocetirizine
Olopatadine Hydrochloride
Carbinoxamine
Clemastine Fumarate
Cyproheptadine Hydrochloride
Diphenhydramine Hydrochloride
Hydroxyzine Hydrochloride
Hydroxyzine Pamoate
Promethazine Hydrochloride
Anti-inflammatories, Inhaled
Corticosteroids
Beclomethasone Dipropionate
Dipropionate
Monohydrate
Budesonide
Ciclesonide
Flunisolide
Fluticasone Propionate
Mometasone Furoate
Monohydrate
Triamcinolone Acetonide
Antileukotrienes
Montelukast Sodium
Zafirlukast
Zileuton
Bronchodilators, Anticholinergic
Aclidinium Bromide
Ipratropium Bromide
Tiotropium Bromide
Monohydrate
Umeclidinium New FDA Approved Drug, 4/30/14
Bronchodilators, Sympathomimetic
Albuterol Sulfate
Arformoterol Tartrate
Epinephrine Bitartrate
Formoterol Fumarate
Dihydrate
Indacaterol inhalation powder Maleate
Levalbuterol Hydrochloride
Metaproterenol Sulfate
Salmeterol Xinafoate
Terbutaline Sulfate
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 37
USP Medicare Model Guidelines v7.0 Page 37 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1682
1683
1684
1685
1686
1687
1688
1689
1690
1691
1692
1693
1694
1695
1696
1697
1698
1699
1700
1701
1702
1703
1704
1705
1706
1707
1708
1709
1710
1711
1712
1713
1714
1715
1716
1717
1718
1719
1720
1721
1722
1723
Olodaterol New FDA Approved Drug, 7/31/14
Cystic Fibrosis Agents
Ivacaftor
Ivacaftor/Lumacaftor New FDA Approved Drug, 7/2/15
Tobramycin dry-powder
inhaler
Aztreonam inhalant solution
Mast Cell Stabilizers
Cromolyn Sodium
Phosphodiesterase Inhibitors, Airways
Disease
Aminophylline Dihydrate
Dyphylline Discontinued by manufacturer
Theophylline
Roflumilast
Pulmonary Antihypertensives
Ambrisentan
Bosentan
Macitentan
Sildenafil Citrate
Tadalafil
Epoprostenol
Iloprost
Treprostinil
Riociguat
Selexipag New FDA Approved Drug, 12/21/15
Respiratory Tract Agents, Other
Acetylcysteine
Alpha-1 Proteinase Inhibitor,
Human
Reclassification; drug moved to newly
renamed category, "Genetic or Enzyme
Disorder: Replacement, Modifiers, Treatment
Budesonide/ Formoterol
fumarate
Fluticasone furoate/
Vilanterol trifenatate
Fluticasone propionate/
Salmeterol
Mometasone furoate/
Formoterol fumerate
dihydrate
Tetrahydrozoline Hydrochloride
Umeclidinum/ Vilanterol
Trifenate
New FDA Approved Drug, 12/16/13
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
Page 38
USP Medicare Model Guidelines v7.0 Page 38 of 38
1
2
A B D E F
USP Category USP Class
Example Part D Eligible
Drugs* Salt/Ester Change Language
1724
1725
1726
1727
1728
1729
1730
1731
1732
1733
1734
1735
1736
1737
1738
1739
1740
1741
1742
1743
1744
1745
1746
1747
1748
1749
1750
1751
1752
1753
1754
1755
Indacaterol/Glycopyrrolate New FDA Approved Drug, 10/29/15
Mepolizumab New FDA Approved Drug, 11/4/15
Pulmonary Fibrosis Agents Nomenclature Change, New class to reflect
therapeutics
Nintedanib New FDA Approved Drug, 10/15/14
Pirfenidone New FDA Approved Drug, 10/15/14
Skeletal Muscle Relaxants
Skeletal Muscle Relaxants Cyclobenzaprine Hydrochloride
Skeletal Muscle Relaxants Metaxalone
Skeletal Muscle Relaxants Methocarbamol
Skeletal Muscle Relaxants Orphenadrine Citrate
Skeletal Muscle Relaxants Carisoprodol
Skeletal Muscle Relaxants Chlorzoxazone
Skeletal Muscle Relaxants Orphenadrine Hydrochloride
Sleep Disorder Agents
Sleep Disorder Agents GABA Receptor Modulators
Sleep Disorder Agents
Sleep Disorder Agents Flurazepam
Sleep Disorder Agents Temazepam
Sleep Disorder Agents Quazepam*
Sleep Disorder Agents
Sleep Disorder Agents Eszopiclone
Sleep Disorder Agents Zaleplon
Sleep Disorder Agents Zolpidem Tartrate
Sleep Disorder Agents Sleep Disorders, Other
Sleep Disorder Agents Armodafinil
Sleep Disorder Agents Doxepin Hydrochloride
Sleep Disorder Agents Modafinil
Sleep Disorder Agents Sodium Oxybate
Sleep Disorder Agents Suvorexant
Sleep Disorder Agents Tasimelteon New FDA Approved Drug, 1/31/14
Sleep Disorder Agents Ramelteon
* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red